Journal of Medicinal Chemistry · 1998 · 77 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyEnzyme InhibitionEnzyme-substrate RecognitionLigand BindingLigand-based DesignProtein Structure ModelingStructural EnzymologyBone Resorption InhibitionCathepsin ActivityCysteine ProteasesEnzymesProtease InhibitorsProtein-ligand Complex ModelingRational DesignSubsite Interactions
Papain has been used as a surrogate enzyme in a drug design effort to obtain potent and selective inhibitors of cathepsin K, a new member of the papain superfamily of cysteine proteases that is selectively and highly expressed in osteoclasts and is implicated in bone resorption. Here we report the crystal structures of two papain-inhibitor complexes and the rational design of novel cathepsin K inhibitors. Unlike previously known crystal structures of papain-inhibitor complexes, our papain structures show ligand binding extending deep within the S'-subsites. The two inhibitor complexes, carbobenzyloxyleucinyl-leucinyl-leucinal and carbobenzyloxy-L-leucinyl-L-leucinyl methoxymethyl ketone, were refined to 2.2- and 2.5-A resolution with R-factors of 0.190 and 0. 217, respectively. The S'-subsite interactions with the inhibitors are dominated by an aromatic-aromatic stacking and an oxygen-aromatic ring edge interaction. The knowledge of S'-subsite interactions led to a design strategy for an inhibitor spanning both subsites and yielded a novel, symmetric inhibitor selective for cathepsin K. Simultaneous exploitation of both S- and S'-sites provides a general strategy for the design of cysteine protease inhibitors having high specificity to their target enzymes.
15
Joost P.H. Drenth, J.N. Jansonius, Roelof Koekoek et al. · Nature · 1968 · 480 citations
Thunderstorms: An Important Mechanism in the Transport of Air Pollutants
Russell R. Dickerson, George J. Huffman, Winston T. Luke et al. · Science · 1987 · 478 citations